DLX1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma is a research paper published in PeerJ (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
The High-level Medical and Health Professionals Training Fund of Yunnan Province
Grant: L-2019028
The “Famous Doctor” Special Fund of Yunnan 10,000 People Plan
Grant: CZ0096
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals